Literature DB >> 9925294

Structural basis for selective inhibition of COX-2 by nimesulide.

G F Fabiola1, V Pattabhi, K Nagarajan.   

Abstract

Nimesulide 1 is a novel nonsteroidal antiinflammatory drug which inhibits the enzyme cyclooxygenase 2 (COX-2) more selectively than cyclooxygenase 1 (COX-1). Molecular modelling studies have been carried out on complexes of 1 with COX-1 and with mutants of COX-1 simulating COX-2. These indicate that the mutations I523V and S516A largely contribute to the selectivity. A comparative study with SC-558 2 has also been performed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9925294     DOI: 10.1016/s0968-0896(98)80012-6

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Automated docking and molecular dynamics simulations of nimesulide in the cyclooxygenase active site of human prostaglandin-endoperoxide synthase-2 (COX-2).

Authors:  R García-Nieto; C Pérez; F Gago
Journal:  J Comput Aided Mol Des       Date:  2000-02       Impact factor: 3.686

2.  Involvement of electron and hydrogen transfers through redox metabolism on activity and toxicity of the nimesulide.

Authors:  Rosivaldo S Borges; Juliana P Oliveira; Rafaelle F Matos; Antonio M J Chaves Neto; Agnaldo S Carneiro; Marta C Monteiro
Journal:  J Mol Model       Date:  2015-06-06       Impact factor: 1.810

3.  Chemometric rationalization of the structural and physicochemical basis for selective cyclooxygenase-2 inhibition: toward more specific ligands.

Authors:  E Filipponi; V Cecchetti; O Tabarrini; D Bonelli; A Fravolini
Journal:  J Comput Aided Mol Des       Date:  2000-03       Impact factor: 3.686

4.  Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries.

Authors:  Christopher P Stanley; Saoirse E O'Sullivan
Journal:  Pharmacol Res       Date:  2014-02-16       Impact factor: 7.658

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.